Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates

  • Yi Wang
  • Sui Fang
  • Bing-qing Xia

Acta Pharmacologica Sinica is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


40 years of APS

40 years of APS

We celebrate the 40th anniversary of Acta Pharmacologica Sinica (APS) with a series of specially commissioned Reviews and Articles across the diverse areas of the journal’s scope, highlighting the advances made in pharmacological research.

Nature Careers